Illumina

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Illumina sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 9 completed top decile by trial count

Illumina: 11 sponsored US clinical trials, none currently recruiting.

Illumina sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. The most-studied condition in this pipeline is Post-natal Cytogenetics, with 1 trials.

Top-decile sponsor footprint

Illumina ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

11 total, page 1 of 1

ACTIVE NOT RECRUITING NA

CardioSeq: Impact of WGS in Individuals With CVD

NCT05656183
ACTIVE NOT RECRUITING

iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders

NCT05049967
COMPLETED

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

NCT04561102
COMPLETED

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

NCT04561089
COMPLETED

NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology

NCT04170985
COMPLETED

A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test

NCT03620110
COMPLETED NA

NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants

NCT03290469
COMPLETED

Collection of Whole Blood Specimens in Pregnant Women

NCT03590678
COMPLETED

Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers

NCT02808494
COMPLETED NA

Single Embryo TrAnsfeR of Euploid Embryo

NCT02268786
COMPLETED

Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test

NCT01426308

Therapeutic Areas

Post-natal Cytogenetics 1
Rare Diseases 1
Genetic Disease 1
Cardiovascular Diseases 1

How the Illumina archive is shaped

11 indexed studies, none listed as recruiting (0% open); 9 completed (82%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Post-natal Cytogenetics (1 trial), 3 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Illumina: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Illumina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share IlluminaAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
Illumina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Illumina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Illumina page

11 registered trials is a research-attention snapshot, not an endorsement of Illumina or any single study.

  • None of Illumina's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Post-natal Cytogenetics is the condition Illumina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post-natal Cytogenetics trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Illumina pipeline card: 11 registered trials from official public datasets.Report a data error.